1. Dobosz M, Mionskowska L, Hac S et al.: Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats. WorldJ Gastroenterol 2004 1; 10(17): 2553-56.
2. Rabenstein T , Fischer B , Wiessner Vl et al.: Lowmolecular- weight heparin does not prevent acute post-ERCP pancreatitis. Gastrointest Endosc 2004; 59(6): 606-13.
3. Barkay O , Niv E, Santo E et al.: Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial. Surg Endosc 2008; 22(9): 1971-76. Epub 2008 Jan 24.
4. Petrov MS: Revising the Atlanta Classification of Acute Pancreatitis: Festina Lente. J GastrointestSurg 2010. (Epub ahead of print)
5. Szmitd J , Kużdżała J : Podstawy Chirurgii t. II; Lampe P: Chirurgia Trzustki; Medycyna Praktyczna, 2010; 993- 1079.
6. Smith M, Kocher HM, Hunt BJ : Aprotinin in severe acute pancreatitis. Int J Clin Pract 2010; 64(1): 84-92. Epub 2009 Jan 28
7. Kuo Pt, Bassett, Digeorge Am, Carpenter Gg; Lipolytic Activity Of Post-Heparin Plasma In Hyperlipemia And Hypolipemia. Circ Res 1965; 16: 221-29.
8. Gabryelewicz A , Niewiarowski S , Prokopowicz J et al.: Heparin and protease inhibitors in the prevention of experimental acute pancreatic necrosis in dogs. Digestion 1969; 2(1): 7-16.
9. Łopaciuk S : Zatory i zakrzepy. PZWL Warszawa 1996.
10. Camerer E, Kataoka H, Kahn M et al.: Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem 2002 3; 277(18): 16081-7. Epub 2002 Feb 15.
11. Warzecha Z ,Dembiński M, Ceranowicz P et al.: Heparyna i jej działanie przeciwzapalne w układzie pokarmowym; Gastroenterologia Pol 2010; 17 (3); 227-233
12. Tyrrell DJ., Horne A P, Holme KR et al.: Heparin in inflammation: Potential therapeutic applications beyond anticoagulation. Adv Pharmacol 1999; 46: 151-208.
13. Finotti P, Corvaja C, Pagetta A : Differential mechanisms for structural and functional alterations of trypsin by heparin, evidence for a specific, radical-generating mechanism at low heparin concentrations. Free Radic Biol Med 1999; 27(11-12): 1378-85.
14. Finotti P, Manente S : Heparin-induced structural and functional alterations of bovine trypsin. Biochem Biophys Acta 1994; 1207: 80-87.
15. Axelsson J , Ferreira M, Adolfsson L et al.: Cytokines in blood from septic patients interact with surface-immobilized heparin. ASAIO J 2010; 56: 48-51.
16. Ceranowicz P, Dembinski A et al.: Protective and therapeutic effect of heparin in acute pancreatitis. J Physiol Pharmacol 2008; 59 Suppl 4: 103-25.
17. Qiu F, Lü XS, Huang YK: Effect of low molecular weight heparin on pancreatic micro-circulation in severe acute pancreatitis in a rodent model. ChinMed J (Engl) 2007; 120(24): 2260-63.
18. Lu XS, Qiu F, Li J Q et al.: Low molecular weight heparin in the treatment of severe acute pancreatitis: a multiple centre prospective clinical study. Asian J Surg 2009; 32(2): 89-94.
19. Hackert T, Werner J, Gebhard MM et al.: Effects of heparin in experimental models of acute pancre atitis and post-ERCP pancreatitis. Surgery 2004; 2(135): 131-38.
20. García PS, Gulati A , Levy J H: The role of thrombin and protease-activated receptors in pain mechanisms. Thromb Haemost 2010; 103(6): 1145-51. Epub 2010 Apr 29.
21. Ewald N, Hardt PD, Kloer HU: Severe hypertriglyceridemia and pancreatitis: presentation and management. Curr Opin Lipidol 2009; 20(6): 497-504.
22. Monga A , Arora A , Makkar R P et al.: Hypertriglyceridemia- induced acute pancreatitis-treatment with heparin and insulin. Indian J Gastroenterol 2003; 22(3): 102-03.
23. Li S , Cao G , Chen X et al.: Low-dose heparin in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Eur J GastroenterolHepatol 2012; 24(5): 477-81.
The use of heparin in the treatment of acute pancreatitis
Keywords:
